申请人:E.R. SQUIBB & SONS, INC.
公开号:EP0296581A2
公开(公告)日:1988-12-28
Compounds of the formula
are disclosed. These compounds interevene in the conversion of angiotensin to angiotensin II by inhibiting renin and thus are useful as anti-hypertensive agents.
式的化合物
已公开。这些化合物通过抑制肾素来干预
血管紧张素向
血管紧张素 II 的转化,因此可用作抗高血压药物。